<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOph</journal-id><journal-title-group><journal-title>Open Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2165-7408</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojoph.2023.131011</article-id><article-id pub-id-type="publisher-id">OJOph-123211</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Resolving Myopic Foveoretinal Detachment by Fovea-Saving Internal Limiting Membrane Peeling: A Case-Series Report
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Miguel</surname><given-names>Angel Quiroz-Reyes</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erick</surname><given-names>Andres Quiroz-Gonzalez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Miguel</surname><given-names>Angel Quiroz-Gonzalez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Virgilio</surname><given-names>Lima-Gomez</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Oftalmologia Integral ABC, Retina Department, Medical and Surgical Assistance Institution (Nonprofit Organization) Affiliated with the Postgraduate Studies Division at the National Autonomous University of Mexico, Mexico City, Mexico</addr-line></aff><aff id="aff2"><addr-line>Juarez Hospital, Public Assistance Institution (Nonprofit Organization), Mexico City, Mexico</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>01</month><year>2023</year></pub-date><volume>13</volume><issue>01</issue><fpage>106</fpage><lpage>121</lpage><history><date date-type="received"><day>17,</day>	<month>December</month>	<year>2022</year></date><date date-type="rev-recd"><day>20,</day>	<month>February</month>	<year>2023</year>	</date><date date-type="accepted"><day>23,</day>	<month>February</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: In highly myopic eyes, myopic foveoschisis (MF), the earliest stage of myopic traction maculopathy (MTM), is present in up to 34% of patients with pathologic myopia and slowly progresses to form foveoretinal detachment (FRD) or macular hole (MH) with or without macular hole retinal detachment (MHRD) as a part of its natural history. 
  Aim: To describe the microstructural and functional results in three highly myopic eyes that underwent macular surgery for early-stage MTM. The last postoperative structural findings were correlated with the final vision and macular automated microperimetry evaluation. 
  Methods: We retrospectively reviewed three highly myopic eyes that underwent successful fovea-saving internal limiting membrane (FS-ILM) macular surgery for chronic FRD at Oftalmologia Integral ABC, Mexico City, Mexico. We performed postoperative multimodal microstructural and functional evaluations, including SD-OCT, SS-OCT, and microperimetric macular examinations. 
  Results: There was a substantial difference between best-corrected visual acuity (BCVA) preoperatively and postoperatively in all three cases. Postoperative surgery was associated with significant improvement in visual acuity confirmed using a paired-sample permutation test. The mean presurgical BCVA value (LogMAR; mean &#177; SE) was ~0.83 &#177; 0.15, and the postsurgical value was ~0.43 &#177; 0.52 (P = 0.00065). The myopic foveoretinal detachment evaluation was ~7.3 &#177; 3.5 months, with a mean postoperative follow-up time of ~14 &#177; 4.08 months. Furthermore, postoperative multimodal imaging tests demonstrated an abnormal microstructural foveal SS-OCT pattern without evidence of macular hole (MH) development at the postoperative follow-up. Macular microperimetry confirmed a subclinical reduced macula threshold sensitivity with an anomalous retinal sensitivity analysis map and a stable central foveal fixation site. 
  Conclusions: Even with the successful microstructural disappearance of myopic macular detachment, the last multidisciplinary functional and structural assessments demonstrated different subclinical macular alterations.
 
</p></abstract><kwd-group><kwd>Automated Microperimetry</kwd><kwd> Myopic Foveoretinal Detachment</kwd><kwd> Myopic Foveoschisis</kwd><kwd> Myopic Macular Hole</kwd><kwd> Myopic Traction Maculopathy</kwd><kwd> Posterior Staphyloma</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>It is estimated that 50% of the world’s population will develop myopia by 2050 (~10% high myopia) [<xref ref-type="bibr" rid="scirp.123211-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref2">2</xref>] . High myopia, a common cause of visual loss, can lead to blindness. High myopia is associated with pathological myopia (PM), which is defined as the progressive deterioration of chorioretinal tissue owing to scleral elongation and posterior staphyloma (PS) development. These pathologic myopic signs are consistent with chorioretinal atrophy, choroidal neovascularization, and slow progressive vitreomacular tractional schisis-like foveomacular thickening [<xref ref-type="bibr" rid="scirp.123211-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref3">3</xref>] .</p><p>Currently, an anterior-posterior axial length of 26.5 mm or more is considered high myopia. There are other macular changes associated with highly myopic eyes (MEs), such as ruptures in Bruch’s membrane and macular atrophy with the absence of macular pigment. PM can be complicated by PS [<xref ref-type="bibr" rid="scirp.123211-ref1">1</xref>] . Earliest-stage myopic traction maculopathy (MTM) has been recently reported as the elongation of Henle’s fiber layer, also known as myopic foveoschisis (MF), which remains connected by Muller cells rather than splitting the retina layers [<xref ref-type="bibr" rid="scirp.123211-ref2">2</xref>] (indicated with white asterisks in Figures 1(a)-(c)), has a thin foveal center inner wall (roof) (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a), white arrow), and involves structural schisis-like thickening formation around the inner and outer layers of the retina (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a) and <xref ref-type="fig" rid="fig1">Figure 1</xref>(c), red arrows). The vitreoretinal relationship is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>(c) with green arrows. This phenomenon has a 66.12% prevalence in women [<xref ref-type="bibr" rid="scirp.123211-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref5">5</xref>] . Reduced thickness of individual collagen fibers, scleral thinning, and localized ectasia have been observed in postmortem MEs [<xref ref-type="bibr" rid="scirp.123211-ref6">6</xref>] . This entity was described by Panozzo and Mercanti in 2004 [<xref ref-type="bibr" rid="scirp.123211-ref4">4</xref>] as MTM, and optical coherence tomography (OCT), a noninvasive optical imaging technique, was used to characterize elusive macular changes, including: 1) vitreomacular traction or epiretinal membrane (ERM), 2) retinal thickening, 3) retinoschisis (RS), and 4) partial- or full-thickness macular hole (MH) in the presence or absence of retinal detachment (RD). Recently, posterior cortex remnants, rigidity of retinal vessels,</p><p>and choroidal thinning have been identified as contributors to traction and degenerative changes, respectively [<xref ref-type="bibr" rid="scirp.123211-ref2">2</xref>] . Although the cause of foveoschisis is not completely understood, tractional forces might play a crucial role in its pathogenesis, particularly when combined with progressive development of PS and subsequent stretching of the posterior retina [<xref ref-type="bibr" rid="scirp.123211-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref8">8</xref>] .</p><p>Shimada et al. [<xref ref-type="bibr" rid="scirp.123211-ref9">9</xref>] classified and structurally defined MF with SD-OCT. The slow evolution of MF progresses to foveoretinal detachment (FRD) and an MH with or without RD in more severe cases, resulting in vision reduction. MF can be detected in up to 34% of eyes with PS and PM [<xref ref-type="bibr" rid="scirp.123211-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref8">8</xref>] - [<xref ref-type="bibr" rid="scirp.123211-ref14">14</xref>] .</p><p>Pathologic scleral thinning [<xref ref-type="bibr" rid="scirp.123211-ref15">15</xref>] combined with subsequent progressive scleral ectasia formation contributes to stretching of critical retinal tissue on the macula [<xref ref-type="bibr" rid="scirp.123211-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref15">15</xref>] . There are few long-term functional results for foveoschisis; therefore, we mainly used visual insight to evaluate the changes in post-surgery vision. Furthermore, vision quality is also affected by central retinal sensitivity, i.e., we intended to determine the structural SS-OCT and functional outcomes in FRD that was successfully surgically treated with the fovea-saving internal limiting membrane (FS-ILM) technique.</p></sec><sec id="s2"><title>2. Case-Series Report/Case Presentation</title><sec id="s2_1"><title>2.1. Examination</title><p>Patients (n = 3, age = 52.3 &#177; 11 years) with significant vision loss were all evaluated by an ophthalmologist and underwent preoperative examinations. No preoperative microperimetry was conducted because of the presence of submacular fluid in these symptomatic myopic FRD patients. Preoperative horizontal microstructural imaging evaluation of the macular region was accomplished with spectral-domain optical coherence tomography (SD-OCT) equipment (Ret-vue-3.4 OCT, Optovue Inc., Fremont, CA). Coherence laser interferometry was used to measure the axial lengths (Zeiss IOL Master 700; Carl Zeiss Meditec, AG, Oberkochen, Germany). We used ultrasonography (A and B Ultrasound Unit, Quantel Medical, Du Bois Loli, Auvergne, France) to perform scleral and vitreoretinal relationship mapping to confirm the PS diagnosis in all eyes. SD-OCT (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany) equipment and SS-OCT Triton equipment (Topcon Medical Systems, Inc., Oakland, NJ 07436) were employed to perform a postoperative microstructural evaluation.</p><p>The standard macular integrity assessment with nonmydriatic confocal scanning laser ophthalmoscope (MAIA Confocal Microperimeter equipment from CenterVue, Fremont, Ca 94539 USA) fundus imaging exam protocol was used to perform automated microperimetry with 37 data measurement points over a 10˚ diameter area with an ~1000 apostilb maximal light stimulus (36-decibel range). Furthermore, the assessment of foveoretinal sensitivity (FRS), macular retinal sensitivity (MRS), fixation location pattern (FLP, also called preferred retinal loci (PRL)), and fixation stability pattern (FSP) was performed by tracking eye movements at 25 times/s. The eye movement distribution over the ophthalmoscope image was plotted from scanning laser vision. The overall site depicting the PRL was assigned a dot for each movement.</p></sec><sec id="s2_2"><title>2.2. Surgical Procedures</title><p>A pars plana vitrectomy (PPV) technique was performed by an experienced retinal surgeon (MAQR) in the three eyes under local anesthesia. A cannula with silicone tape (25-gauge and 2-mm soft top) and active suction was used to remove cortical vitreous from the retinal surface with triamcinolone acetonide (Kenalog 40 mg/mL, Bristol-Myers, USA). Surgical macular evaluation was performed using an ophthalmic solution (0.15%) of trypan blue (MembraneBlue<sup>TM</sup> 0.15%, Dutch Ophthalmic, USA) and 0.10 mL of Brilliant Blue-G (BBG) at 0.25 mg/mL (C<sub>47</sub>H<sub>48</sub>NaO<sub>7</sub>S<sub>2</sub>) to facilitate the manipulation of the stained ILM, complemented with 25-G three-port PPV equipment (Constellation Vision System, Alcon Laboratories, Inc., USA) with a cut rate of ~7000/CPM, fine grasping vitreoretinal Tano ILM forceps (24-G, Alcon Laboratories, Inc., USA), and a 25-G membrane scraper, assisted with a 25-G Finesse microinstrument (Grieshaber<sup>&#174;</sup>. Alcon Laboratories, Inc., USA) with high surgical precision for manipulation of the ILM flap. At the end of the procedure, we employed a bubble of perfluoropropane gas at 15% as a long-lasting tamponade.</p></sec><sec id="s2_3"><title>2.3. Clinical Case 1</title><p>In this case, a 65-year-old female patient suffered from aggravated symptomatic metamorphopsia, severe myopia, and progressive central vision loss in her right eye, and both eyes exhibited PS. <xref ref-type="fig" rid="fig2">Figure 2</xref>a illustrates the right eye with an axial length of ~28.92 mm, which underwent surgery due to a one-year history of structural FRD with distorted vision, depicted using yellow arrows in the figure. Her preoperative BCVA was 20/200 (1.00 logMAR). This eye underwent a 25-gauge PPV with an FS-ILM surgical technique. Using perfluoropropane (15%), tamponade fluid-air-gas exchange was performed. After 19 months, SS-OCT imaging and longitudinal follow-up indicated a flat macula without evidence of FRD, which is depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(a1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(a2). Recovered outer retina OCT biomarkers are depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(a1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(a2) using a dark yellow arrow, and some superficial retinal dimpling superior and temporal to the fovea are depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(a1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(a2), respectively, using white arrows. The thin RPE over the macula did not suffer any postoperative deterioration on the autofluorescence examination (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a3)). The microperimetry control examination images are depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(control), <xref ref-type="fig" rid="fig3">Figure 3</xref>(a) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(b). The microperimetry examination showed a stable FSP, and the FLP was documented as foveocentral, as depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(a1) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(a2). The final long-term postoperative SS-OCT is depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(d) without recurrence of the FRD or progression to MH. The postoperative BCVA was ~20/25 (0.01 logMAR).</p></sec><sec id="s2_4"><title>2.4. Clinical Case 2</title><p>In this case, a 46-year-old woman with 3 months of persistent, disabling metamorphopsia and troublesome and high myopia underwent a standard 25-gauge three-port PPV followed by macular surgery on her phakic right eye for a very symptomatic focal and well-defined FRD, as indicated in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b) using a yellow arrow, and persistent hyaloidal macular traction was observed (green arrows). The inner retinal schisis-like thickening foveoschisis is depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b) using a red arrow. Her outer retina layer biomarkers were distorted with localized subfoveal FRD, as depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b) using a yellow arrow. The patient underwent macular surgery involving a BBG dye-assisted FS-ILM surgical technique and perfluoropropane (15%) long-acting nonexpandable gas tamponade. The preoperative BCVA was 20/100 (0.7 logMAR), with a shallow PS (data not shown) and an axial length of ~27.7 mm. The ultimate postoperative</p><p>BCVA was 20/25 after a 14-month follow-up (0.10 logMAR). Postoperative structural OCT evaluation showed a resolved FRD, as depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(b), released hyaloidal traction, a flat macula with a good foveal and macular profile and evidence of some superficial dimpling on the en face examination, as depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(b2). The autofluorescence in this phakic eye shows some media lens-induced opacity and evidence of DONFL appearance induced by ILM removal; the image shows only mild peripapillary pigment atrophy without evidence of foveal RPE alteration (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b3)). The microperimetric evaluation results were in the normal range, as depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(b1) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(b2). The final SS-OCT aspect is depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(e).</p></sec><sec id="s2_5"><title>2.5. Clinical Case 3</title><p>In this case, a 49-year-old woman presented with symptoms of aggravating symptomatic metamorphopsia in the right eye for more than seven months, accompanied by progressive vision loss. The myopic spherical equivalent was -22.90 diopters. The preoperative BCVA was ~20/120 (0.80 logMAR) with normal applanation intraocular tension (10 mmHg). An axial length of ~30.76 mm and a deep central PS were observed by fundus photography (not shown), fundoscopy, and SS-OCT evaluation. The findings of the preoperative spectral-domain (SD)-OCT are consistent with ERM proliferation (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c) using green arrows); foveal detachment with a remarkable amount of central submacular fluid is depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>(c) using yellow arrows, and schisis-like macular thickening is depicted using red arrows. Macular surgery was performed using an FS-ILM surgical technique. As a result of the patient’s refractory FRD and increased foveal symptomatology, a second round of surgery was performed using BBG dye guidance to distinguish epiretinal and ILM residues. Finally, air-fluid exchange with a mixture of octafluoropropane gas (15% nonexpandable concentration) was safely performed. On crossline, vertical and horizontal SS-OCT B-scan postoperative evaluations, no clinical evidence of residual macular ERM proliferation was observed on the superficial aspect of the macula (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c1) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(c2)). The foveomacular region remained attached at the 9-month last evaluation visit, with a BCVA of ~20/40 (0.30 logMAR). Some vitreous cortical remnants inferior to the fovea were identified (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c1), green arrow) with localized DONFL defects temporal to the fovea (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c2), white arrow). The autofluorescence imaging evaluation showed peripapillary and extrafoveal areas of well-defined hypoautofluorescence and faint foveal hypoautofluorescence with a mild surrounding halo of hyperautofluorescence (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c3)). Retinal sensitivity assessment confirmed abnormal macular sensitivity, with a mild decrease in foveal threshold sensitivity, as depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(c1) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(c2). The last long-term SS-OCT structural evaluation is depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>(f).</p><p><xref ref-type="table" rid="table1">Table 1</xref> summarizes the preoperative and postoperative structural and functional findings of the three eyes.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Summary of preoperative and postoperative structural and functional findings</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Findings</th><th align="center" valign="middle" >Case 1 (65 F)</th><th align="center" valign="middle" >Case 2 (46 F)</th><th align="center" valign="middle" >Case 3 (49 F)</th><th align="center" valign="middle" >Observations</th></tr></thead><tr><td align="center" valign="middle" >Evolution of FRD</td><td align="center" valign="middle" >12 months</td><td align="center" valign="middle" >3 months</td><td align="center" valign="middle" >7 months</td><td align="center" valign="middle" >Mean = 7.3 months</td></tr><tr><td align="center" valign="middle" >Follow-up</td><td align="center" valign="middle" >19 months</td><td align="center" valign="middle" >14 months</td><td align="center" valign="middle" >9 months</td><td align="center" valign="middle" >Mean = 14.0 months</td></tr><tr><td align="center" valign="middle" >Preoperative BCVA</td><td align="center" valign="middle" >LogMAR 1.00 (20/200)</td><td align="center" valign="middle" >LogMAR 0.70 (20/100)</td><td align="center" valign="middle" >LogMAR 0.80 (20/120)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Postoperative BCVA</td><td align="center" valign="middle" >LogMAR 0.10 (20/25)</td><td align="center" valign="middle" >LogMAR 0.10 (20/25)</td><td align="center" valign="middle" >LogMAR 0.30 (20/40)</td><td align="center" valign="middle" >Snellen equivalent</td></tr><tr><td align="center" valign="middle" >Preoperative SD-OCT</td><td align="center" valign="middle" >FRD + ERM</td><td align="center" valign="middle" >FRD</td><td align="center" valign="middle" >FRD+ERM</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Axial length</td><td align="center" valign="middle" >28.92 mm</td><td align="center" valign="middle" >27.70 mm</td><td align="center" valign="middle" >30.76 mm</td><td align="center" valign="middle" >Mean = 29.12 mm</td></tr><tr><td align="center" valign="middle" >CSFT</td><td align="center" valign="middle" >Less than 180 &#181;m</td><td align="center" valign="middle" >Up to 220 &#181;m</td><td align="center" valign="middle" >Less than 180 &#181;m</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Foveal contour</td><td align="center" valign="middle" >Disrupted</td><td align="center" valign="middle" >Recovered and preserved</td><td align="center" valign="middle" >Disrupted</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >ERM</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Mild, inferotemporal to the fovea</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Residual SRF</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Residual nasal to fovea</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Residual foveoschisis</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Nasal and extrafoveal</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Subfoveal EZ</td><td align="center" valign="middle" >Mild disruption</td><td align="center" valign="middle" >Preserved</td><td align="center" valign="middle" >Moderate disruption</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >RPE changes</td><td align="center" valign="middle" >Faint central atrophy</td><td align="center" valign="middle" >Not detected</td><td align="center" valign="middle" >Mild central atrophy</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >DONFL defects (dimples)</td><td align="center" valign="middle" >Isolated dimples</td><td align="center" valign="middle" >Mild dimples on en-face OCT</td><td align="center" valign="middle" >Not detected</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >MRS</td><td align="center" valign="middle" >Reduced</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >Reduced</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >FRS</td><td align="center" valign="middle" >Mild reduction</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >Deeply reduced</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >FSP</td><td align="center" valign="middle" >Stable</td><td align="center" valign="middle" >Stable</td><td align="center" valign="middle" >Stable</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >FLP (PRL)</td><td align="center" valign="middle" >Foveocentral</td><td align="center" valign="middle" >Foveocentral</td><td align="center" valign="middle" >Foveocentral</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >RSAM</td><td align="center" valign="middle" >Abnormal</td><td align="center" valign="middle" >Recovered to normal</td><td align="center" valign="middle" >Depressed abnormal</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>BCVA, best-corrected visual acuity; SD-OCT, spectral-domain optical coherence tomography; SRF, subretinal fluid; CSFT, central subfoveal thickness; EZ, ellipsoid zone; ERM, epiretinal membrane; DONFL, dissociated optic nerve fiber layer; FRD, foveoretinal detachment; MRS, mean retinal sensitivity; FRS, foveal retinal sensitivity; FSP, fixation stability pattern; FLP, fixation location pattern; PRL, preferred retinal loci; RSAM, retinal sensitivity analysis map.</p></sec></sec><sec id="s3"><title>3. Discussion</title><p>We performed vitrectomy with an FS-ILM removal technique in three consecutive, symptomatic, and high MEs with FRD, and postoperative structural and functional evaluations were performed in the three cases. Although none of the patients developed MH, one demonstrated evidence of mild extrafoveal epiretinal membrane reproliferation regardless of ILM removal in an updated manner. Evidence of a significant reduction in macular sensitivity was demonstrated by the results of functional evaluations. Microperimetry showed stable fixation patterns and central location patterns in the three eyes. Two eyes showed subclinical evidence of reduced retinal sensitivity and a very abnormal retinal sensitivity in the analysis map that correlated with the postoperative BCVA.</p><p>Panozzo and Mercanti [<xref ref-type="bibr" rid="scirp.123211-ref4">4</xref>] concluded that the reflattening of the macula can be facilitated by releasing the epimacular and vitreous traction at the early stages of MTM, which prevents the development of an MH or RD.</p><p>Shimada et al. [<xref ref-type="bibr" rid="scirp.123211-ref12">12</xref>] prospectively reported progressive macular thickening as a sign of progression to foveomacular retinoschisis and FRD. Although the progression of foveomacular retinoschisis to MH formation has been reported recently, the myriad pathogenic properties, especially at the early stages of MTM, are still not well understood; therefore, we speculated that early-stage detection of structural signs of the disorder in symptomatic eyes may improve the surgical outcomes. Patients with early-stage MTM, particularly MF, are among the least symptomatic when presented to retina specialists. This kind of early stage might persist for a long time with chronic subclinical progression before macular function is substantially impaired [<xref ref-type="bibr" rid="scirp.123211-ref11">11</xref>] . This observation confirms the proposals by Takano and Kishi in their classical study [<xref ref-type="bibr" rid="scirp.123211-ref10">10</xref>] and others [<xref ref-type="bibr" rid="scirp.123211-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref16">16</xref>] regarding MF occurrence at an earlier stage or as a direct precursor lesion followed by development into FRD. Moreover, Uchida et al. [<xref ref-type="bibr" rid="scirp.123211-ref13">13</xref>] showed that during the follow-up, 80% of eyes (n = 10) progressed to FRD, followed by developing a partial- or full-thickness MH. Hayashi et al. [<xref ref-type="bibr" rid="scirp.123211-ref17">17</xref>] evaluated 806 eyes in 429 patients (~34% male and ~66% female). It was confirmed that the progression of foveomacular retinoschisis to FRD occurred in approximately 41.0% of eyes, and progression to partial-thickness MH in ~20.70% of eyes. It has been reported that initial findings such as thickening of the outer retina layers with tissue irregularities were associated with the development of a partial-thickness macular defect associated with shallow, focal FRD; the partial-thickness defect elevates the upper edge of the macula, leading to enlargement of the localized FRD [<xref ref-type="bibr" rid="scirp.123211-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref17">17</xref>] .</p><p>Baba et al. [<xref ref-type="bibr" rid="scirp.123211-ref18">18</xref>] found an incidence of up to 9% of eyes with high myopia and PS that eventually developed FRD. According to previous studies, these maladies could be treated with vitrectomy, posterior hyaloidal removal, different ILM stripping techniques and gas tamponade [<xref ref-type="bibr" rid="scirp.123211-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref21">21</xref>] .</p><p>Currently, revised techniques, such as long-term gas with the FS-ILM surgical technique, are accessible for both primary and refractory cases, subsequently resulting in foveal reattachment and offering substantial visual improvement [<xref ref-type="bibr" rid="scirp.123211-ref22">22</xref>] . However, there are inherent risks associated with ILM removal, including: 1) thinning of superficial retinal layers, 2) superficial retinal tiny holes, 3) dissociated optic nerve fiber layer (DONFL) defects and 4) partial- or full-thickness MH formation. Shimada et al. [<xref ref-type="bibr" rid="scirp.123211-ref23">23</xref>] attempted to avoid these risks in eyes with an FRD by using a modified technique called the foveal-sparing technique. They found that no eyes developed MH with this technique. Up to ~16.7% of eyes progressed and finally developed a full-thickness MH subsequent to total classical removal or nonsparing ILM removal [<xref ref-type="bibr" rid="scirp.123211-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref24">24</xref>] . In this way, progression to FRD may be indicative of a poor prognosis leading to MH formation [<xref ref-type="bibr" rid="scirp.123211-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref25">25</xref>] .</p><p>Herein, we report a case series of three eyes showing symptomatic FRD. The best postoperative final logMAR vision was found using long-acting gas with the FS-ILM technique, with no observed MH development during the follow-up. An almost normal postoperative SS-OCT pattern was noticed in only one eye, and the observed postoperative visual improvement in these three FRD eyes was significant. One limitation of this report is that no standardization and correlation of the most important OCT biomarkers in this entity with the functional results were available, and there was a lack of postoperative multifocal electroretinography (mfERG) evaluation. Therefore, this study can only be empirically used to correlate functional results until an international and standardized SD-OCT biomarker classification is established. At present, these described biomarkers suggest that defects, including an unusual foveal contour, ELM line disruptions, segmented RPE, DONFL defects seen on en face imaging, and subfoveal EZ disruptions, may be tomographic indicators of vision. However, the effect of these tomographic microstructures, their reactive recovery to surgical procedures, and their potential correlation with the final postoperative BCVA are unknown.</p><p>The appearance of DONFL defects may be a result of ILM removal, and these observations were discussed by Alkabes et al. [<xref ref-type="bibr" rid="scirp.123211-ref26">26</xref>] . However, in comparison with automated microperimetry and mfERG, its effect on macular function remains debated. Huang et al. [<xref ref-type="bibr" rid="scirp.123211-ref27">27</xref>] considered myopic FRD as one of the most crucial postsurgery risk factors for developing MHRD in MTM, and in contrast to their findings, Al-Badawi et al. [<xref ref-type="bibr" rid="scirp.123211-ref25">25</xref>] recently reported a prospective study where there was no difference in the development of MHRD when the ILM was completely removed with a total classical technique, which was comparable to the results of the FS-ILM technique [<xref ref-type="bibr" rid="scirp.123211-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref27">27</xref>] .</p><p>The FS-ILM technique inhibits the proliferation of epiretinal macular membranes and hypothetically halts the progression of RS and FRD to MH by reducing ILM rigidity [<xref ref-type="bibr" rid="scirp.123211-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref27">27</xref>] ; however, some other complications, such as macular atrophy, lamellar hole (partial-thickness MH), and thinning of the inner layers of the retina, have been previously described [<xref ref-type="bibr" rid="scirp.123211-ref27">27</xref>] . It is worth noting that the preoperative presence of FRD constitutes a risk factor for the development of MHRD [<xref ref-type="bibr" rid="scirp.123211-ref27">27</xref>] , but a timely and uneventful surgical technique resolved macular traction, flattening the FRD without progression, as described in this report. Likewise, many novel surgical methods have been recently proposed for the unexpected complication of a postoperative MH, including autologous neurosensory retinal free patch transplantation [<xref ref-type="bibr" rid="scirp.123211-ref28">28</xref>] , lens capsular flap transplantation [<xref ref-type="bibr" rid="scirp.123211-ref29">29</xref>] , ILM repositioning with autologous blood [<xref ref-type="bibr" rid="scirp.123211-ref30">30</xref>] and inverted ILM insertion [<xref ref-type="bibr" rid="scirp.123211-ref31">31</xref>] .</p><p>In this report, despite surgical reattachment of the FRD within the first months, chronic separation of the photoreceptors and presence of stagnant SRF in contact with the RPE were considered the causes of photoreceptor damage. As shown in two eyes, abnormal structural SD-OCT findings correlated with macular regions that were abnormal on automated microperimetry. The retinal origin of the defect is thus highly certain. Eye movements and changes in retinal fixation can be overcome with microperimetry, which provides accurate retina-related sensitivity data. The strength of this study is that it is among the first studies to evaluate the functional and anatomical results in a series of three patients with high MEs who underwent FS-ILM using the best-known biomarkers to correlate functional results. However, this study presents some limitations because the only functional evaluations available preoperatively were BCVA and the Amsler test. Additionally, when FRD patients had profound vision loss and/or no clear central vision, preoperative microperimetry testing showed only false functional traces with no preoperative clinical relevance. Nevertheless, thorough microperimetry was performed during the final postoperative visit.</p><p>In summary, in the early stages of MTM, there are four major sources of traction on the retinal surface: adherent vitreous cortex, vitreomacular traction, epiretinal membrane presence, and ILM [<xref ref-type="bibr" rid="scirp.123211-ref32">32</xref>] . ILM inflexibility is considered a major cause of this maculopathy. Furthermore, ILM peeling reduces the rigidity that allows the retina to better conform to PS [<xref ref-type="bibr" rid="scirp.123211-ref33">33</xref>] . In FS-ILM, the fovea is reattached in a manner comparable to that of classical total ILM removal. This suggests that tangential traction is likely released by FS-ILM similar to the classical technique. In terms of visual prognosis, both the FS-ILM and classical total ILM removal techniques showed BCVA improvement after surgery. Such visual improvement by both types of surgical techniques might be attributed to foveoschisis restoration and the low occurrence of macular holes [<xref ref-type="bibr" rid="scirp.123211-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.123211-ref25">25</xref>] . However, according to one meta-analysis [<xref ref-type="bibr" rid="scirp.123211-ref34">34</xref>] , the FS-ILM eye group achieved a better postoperative BCVA than the classical total ILM removal group.</p><p>In this case-series report, the anatomic outcomes were similar, with no evidence of residual RS or progression to MH or MHRD in either eye. The results favored the FS-ILM technique after assessing the structural results and the change in BCVA from baseline. This result indicates that the FS-ILM technique achieved acceptable outcomes in terms of functional postoperative vision. Randomized clinical trials or MTM full-spectrum systematic reviews with meta-analyses should be conducted to investigate the best surgical approach in the different MTM stages and to investigate the rates at which postoperative MH and MHRD occur. We consider that a better pathogenic classification of MTM stages is an outcome of the broad application of OCT and vitrectomy [<xref ref-type="bibr" rid="scirp.123211-ref35">35</xref>] , since the full spectrum of MTM is increasingly being considered as a single clinical disorder with a wide range of clinical phenotypes ranging from RS to MH, followed by FRD and RD [<xref ref-type="bibr" rid="scirp.123211-ref36">36</xref>] .</p></sec><sec id="s4"><title>4. Conclusion</title><p>In conclusion, to minimize damage to photoreceptors and the RPE, MTM-induced FRD should be treated as soon as possible. It is unclear whether the observed functional changes are associated with prolonged exposure to subretinal fluid or secondary to mechanisms related to photoreceptor perfusion alterations that in turn are due to surgical maneuvers or to ILM surgical removal. Only subclinical damage permits successful early foveomacular anatomical reattachment. In this way, certain highly myopic eyes with PM, abnormal premacular tissues, and PS are at risk of developing MTM that in early stages should be periodically monitored, and if progression is suspected, a timely, well-planned surgical intervention should be performed.</p></sec><sec id="s5"><title>Acknowledgements</title><p>We would like to express our sincere appreciation to the technical staff of the Retina Specialists Unit at Oftalmologia Integral ABC (Nonprofit Medical and Surgical Organization), Mexico City, Mexico, which is affiliated with the Postgraduate Division Studies at the National Autonomous University of Mexico.</p></sec><sec id="s6"><title>List of Abbreviations (Acronyms)</title><p>3-D, three-dimensional; ATN, classification system for myopic maculopathy including atrophic (A), tractional (T) and neovascular (N) components; BBG, Brilliant Blue G; BCVA, best-corrected visual acuity; ELM, external limiting membrane; ERM, epiretinal membrane; FRD, foveoretinal detachment; ILM, internal limiting membrane; logMAR, logarithm of the minimum angle of resolution; ME, myopic eye; MF, myopic foveoschisis; MH, macular holes; MTM, myopic traction maculopathy; OCT, optical coherence tomography; PM, pathological myopia; PS, posterior staphyloma; RPE, retinal pigment epithelial; RS, retinoschisis; SD, spectral domain; SS, swept-source.</p></sec><sec id="s7"><title>Statement of Ethics</title><p>The protocol for this study was approved by the Institutional Review Board (IRB) of Oftalmologia Integral ABC on May 10, 2022. All protocols adhered to the criteria of the Declaration of Helsinki of the World Medical Association. All three patients gave informed consent to the publication of this case report and any accompanying images. According to the Declaration of Helsinki, this report does not contain any personal information that could identify patients.</p></sec><sec id="s8"><title>Funding Sources</title><p>This research received no external financial support.</p></sec><sec id="s9"><title>Author Contributions</title><p>Quiroz-Reyes MA conceptualized this work and drafted and reviewed the manuscript, Quiroz-Gonzalez EA was responsible for statistics and table generation, Quiroz-Gonzalez MA was responsible for figures and artwork, and Lima-Gomez V performed the final revision.</p></sec><sec id="s10"><title>Data Availability Statement</title><p>All the data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.</p></sec><sec id="s11"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s12"><title>Cite this paper</title><p>Quiroz-Reyes, M.A., Quiroz-Gonzalez, E.A., Quiroz-Gonzalez, M.A. and Lima-Gomez, V. (2023) Resolving Myopic Foveoretinal Detachment by Fovea-Saving Internal Limiting Membrane Peeling: A Case-Series Report. Open Journal of Ophthalmology, 13, 106-121. https://doi.org/10.4236/ojoph.2023.131011</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123211-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M. and Rose, K.A. (2018) The Epidemics of Myopia: Aetiology and Prevention. Progress in Retinal and Eye Research, 62, 134-149. https://doi.org/10.1016/j.preteyeres.2017.09.004</mixed-citation></ref><ref id="scirp.123211-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Xu, L., Wang, Y., Li, Y., Wang, Y., Cui, T., Li, J. and Jonas, J.B. (2006) Causes of Blindness and Visual Impairment in Urban and Rural Areas in Beijing: The Beijing Eye Study. Ophthalmology, 113, 1134.e1-11. https://doi.org/10.1016/j.ophtha.2006.01.035</mixed-citation></ref><ref id="scirp.123211-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Iwase, A., Araie, M., Tomidokoro, A., Yamamoto, T., Shimizu, H., Kitazawa, Y. and Tajimi Study Group (2006) Prevalence and Causes of Low Vision and Blindness in a Japanese Adult Population: The Tajimi Study. Ophthalmology, 113, 1354-1362. https://doi.org/10.1016/j.ophtha.2006.04.022</mixed-citation></ref><ref id="scirp.123211-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Panozzo, G. and Mercanti, A. (2004) Optical Coherence Tomography Findings in Myopic Traction Maculopathy. Archives of Ophthalmology, 122, 1455-1460. https://doi.org/10.1001/archopht.122.10.1455</mixed-citation></ref><ref id="scirp.123211-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Panozzo, G. and Mercanti, A. (2007) Vitrectomy for Myopic Traction Maculopathy. Archives of Ophthalmology, 125, 767-772. https://doi.org/10.1001/archopht.125.6.767</mixed-citation></ref><ref id="scirp.123211-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Rada, J.A., Shelton, S. and Norton, T.T. (2006) The Sclera and Myopia. Experimental Eye Research, 82, 185-200. https://doi.org/10.1016/j.exer.2005.08.009</mixed-citation></ref><ref id="scirp.123211-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ikuno, Y. and Tano, Y. (2003) Early Macular Holes with Retinoschisis in Highly Myopic Eyes. American Journal of Ophthalmology, 136, 741-744. https://doi.org/10.1016/S0002-9394(03)00319-2</mixed-citation></ref><ref id="scirp.123211-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Margolis, R. and Spaide, R.F. (2009) A Pilot Study of Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Normal Eyes. American Journal of Ophthalmology, 147, 811-815. https://doi.org/10.1016/j.ajo.2008.12.008</mixed-citation></ref><ref id="scirp.123211-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Shimada, N., Tanaka, Y., Tokoro, T. and Ohno-Matsui, K. (2013) Natural Course of Myopic Traction Maculopathy and Factors Associated with Progression or Resolution. American Journal of Ophthalmology, 156, 948-957.e1. https://doi.org/10.1016/j.ajo.2013.06.031</mixed-citation></ref><ref id="scirp.123211-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Takano, M. and Kishi, S. (1999) Foveal Retinoschisis and Retinal Detachment in Severely Myopic Eyes with Posterior Staphyloma. American Journal of Ophthalmology, 128, 472-476. https://doi.org/10.1016/S0002-9394(99)00186-5</mixed-citation></ref><ref id="scirp.123211-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ikuno, Y., Gomi, F. and Tano, Y. (2005) Potent Retinal Arteriolar Traction as a Possible Cause of Myopic Foveoschisis. American Journal of Ophthalmology, 139, 462-467. https://doi.org/10.1016/j.ajo.2004.09.078</mixed-citation></ref><ref id="scirp.123211-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Shimada, N., Ohno-Matsui, K., Baba, T., Futagami, S., Tokoro, T. and Mochizuki, M. (2006) Natural Course of Macular Retinoschisis in Highly Myopic Eyes without Macular Hole or Retinal Detachment. American Journal of Ophthalmology, 142, 497-500. https://doi.org/10.1016/j.ajo.2006.03.048</mixed-citation></ref><ref id="scirp.123211-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Uchida, A., Shinoda, H., Koto, T., Mochimaru, H., Nagai, N., Tsubota, K. and Ozawa, Y. (2014) Vitrectomy for Myopic Foveoschisis with Internal Limiting Membrane Peeling and No Gas Tamponade. Retina, 34, 455-460. https://doi.org/10.1097/IAE.0b013e3182a0e477</mixed-citation></ref><ref id="scirp.123211-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Quiroz-Reyes, M., Nieto, A., Quiroz-Gonzalez, E., Quiroz-Gonzalez, M., Montano, M., Morales-Navarro, J. and Gómez, V. (2020) Timing of Vitrectomy in Myopic Traction Maculopathy: A Long Term Follow Up Report of a Hispanic Population. American Journal of Medicine and Surgery, 1, 7-14. https://doi.org/10.17605/OSF.IO/FA783</mixed-citation></ref><ref id="scirp.123211-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ohno-Matsui, K., Kawasaki, R., Jonas, J.B., Cheung, C.M., Saw, S.M., Verhoeven, V.J., Klaver, C.C., Moriyama, M., Shinohara, K., Kawasaki, Y., Yamazaki, M., Meuer, S., Ishibashi, T., Yasuda, M., Yamashita, H., Sugano, A., Wang, J.J., Mitchell, P., Wong, T.Y. and META-Analysis for Pathologic Myopia (META-PM) Study Group (2015) International Photographic Classification and Grading System for Myopic Maculopathy. American Journal of Ophthalmology, 159, 877-883.e7. https://doi.org/10.1016/j.ajo.2015.01.022</mixed-citation></ref><ref id="scirp.123211-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Shimada, N., Ohno-Matsui, K., Yoshida, T., Sugamoto, Y., Tokoro, T. and Mochizuki, M. (2008) Progression from Macular Retinoschisis to Retinal Detachment in Highly Myopic Eyes Is Associated with Outer Lamellar Hole Formation. British Journal of Ophthalmology, 92, 762-764. https://doi.org/10.1136/bjo.2007.131359</mixed-citation></ref><ref id="scirp.123211-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hayashi, K., Ohno-Matsui, K., Shimada, N., Moriyama, M., Kojima, A., Hayashi, W., Yasuzumi, K., Nagaoka, N., Saka, N., Yoshida, T., Tokoro, T. and Mochizuki, M. (2010) Long-Term Pattern of Progression of Myopic Maculopathy: A Natural History Study. Ophthalmology, 117, 1595-1611.e4. https://doi.org/10.1016/j.ophtha.2009.11.003</mixed-citation></ref><ref id="scirp.123211-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Baba, T., Ohno-Matsui, K., Futagami, S., Yoshida, T., Yasuzumi, K., Kojima, A., Tokoro, T. and Mochizuki, M. (2003) Prevalence and Characteristics of Foveal Retinal Detachment without Macular Hole in High Myopia. American Journal of Ophthalmology, 135, 338-342. https://doi.org/10.1016/S0002-9394(02)01937-2</mixed-citation></ref><ref id="scirp.123211-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Gaucher, D., Haouchine, B., Tadayoni, R., Massin, P., Erginay, A., Benhamou, N. and Gaudric, A. (2007) Long-Term Follow-Up of High Myopic Foveoschisis: Natural Course and Surgical Outcome. American Journal of Ophthalmology, 143, 455-462. https://doi.org/10.1016/j.ajo.2006.10.053</mixed-citation></ref><ref id="scirp.123211-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Spaide, R.F. and Fisher, Y. (2005) Removal of Adherent Cortical Vitreous Plaques without Removing the Internal Limiting Membrane in the Repair of Macular Detachments in Highly Myopic Eyes. Retina, 25, 290-295. https://doi.org/10.1097/00006982-200504000-00007</mixed-citation></ref><ref id="scirp.123211-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Kumagai, K., Furukawa, M., Ogino, N. and Larson, E. (2010) Factors Correlated with Postoperative Visual Acuity after Vitrectomy and Internal Limiting Membrane Peeling for Myopic Foveoschisis. Retina, 30, 874-880. https://doi.org/10.1097/IAE.0b013e3181c703fc</mixed-citation></ref><ref id="scirp.123211-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kobayashi, H. and Kishi, S. (2003) Vitreous Surgery for Highly Myopic Eyes with Foveal Detachment and Retinoschisis. Ophthalmology, 110, 1702-1707. https://doi.org/10.1016/S0161-6420(03)00714-0</mixed-citation></ref><ref id="scirp.123211-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Shimada, N., Sugamoto, Y., Ogawa, M., Takase, H. and Ohno-Matsui, K. (2012) Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy. American Journal of Ophthalmology, 154, 693-701. https://doi.org/10.1016/j.ajo.2012.04.013</mixed-citation></ref><ref id="scirp.123211-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Seppey, C. and Wolfensberger, T.J. (2017) Vitrectomy with Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Foveoschisis. Klinische Monatsbl&amp;#228;tter für Augenheilkunde, 234, 497-500. https://doi.org/10.1055/s-0043-104429</mixed-citation></ref><ref id="scirp.123211-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Al-Badawi, A.H., Abdelhakim, M., Macky, T.A. and Mortada, H.A. (2019) Efficacy of Non-Fovea-Sparing ILM Peeling for Symptomatic Myopic Foveoschisis with and without Macular Hole. British Journal of Ophthalmology, 103, 257-263. https://doi.org/10.1136/bjophthalmol-2017-311775</mixed-citation></ref><ref id="scirp.123211-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Alkabes, M., Salinas, C., Vitale, L., Bures-Jelstrup, A., Nucci, P. and Mateo, C. (2011) En Face Optical Coherence Tomography of Inner Retinal Defects after Internal Limiting Membrane Peeling for Idiopathic Macular Hole. Investigative Ophthalmology &amp; Visual Science, 52, 8349-8355. https://doi.org/10.1167/iovs.11-8043</mixed-citation></ref><ref id="scirp.123211-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Huang, Y., Huang, W., Ng, D.S.C. and Duan, A. (2017) Risk Factors for Development of Macular Hole Retinal Detachment after Pars Plana Vitrectomy for Pathologic Myopic Foveoschisis. Retina, 37, 1049-1054. https://doi.org/10.1097/IAE.0000000000001322</mixed-citation></ref><ref id="scirp.123211-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">De Giacinto, C., D'Aloisio, R., Cirigliano, G., Pastore, M.R. and Tognetto, D. (2019) Autologous Neurosensory Retinal Free Patch Transplantation for Persistent Full-Thickness Macular Hole. International Ophthalmology, 39, 1147-1150. https://doi.org/10.1007/s10792-018-0904-4</mixed-citation></ref><ref id="scirp.123211-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Chen, S.N. and Yang, C.M. (2016) Lens Capsular Flap Transplantation in the Management of Refractory Macular Hole from Multiple Etiologies. Retina, 36, 163-170. https://doi.org/10.1097/IAE.0000000000000674</mixed-citation></ref><ref id="scirp.123211-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Lai, C.C., Chen, Y.P., Wang, N.K., Chuang, L.H., Liu, L., Chen, K.J., Hwang, Y.S., Wu, W.C. and Chen, T.L. (2015) Vitrectomy with Internal Limiting Membrane Repositioning and Autologous Blood for Macular Hole Retinal Detachment in Highly Myopic Eyes. Ophthalmology, 122, 1889-1898. https://doi.org/10.1016/j.ophtha.2015.05.040</mixed-citation></ref><ref id="scirp.123211-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Kuriyama, S., Hayashi, H., Jingami, Y., Kuramoto, N., Akita, J. and Matsumoto, M. (2013) Efficacy of Inverted Internal Limiting Membrane Flap Technique for the Treatment of Macular Hole in High Myopia. American Journal of Ophthalmology, 156, 125-131.e1. https://doi.org/10.1016/j.ophtha.2015.05.040</mixed-citation></ref><ref id="scirp.123211-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Johnson, M.W. (2012) Myopic Traction Maculopathy: Pathogenic Mechanisms and Surgical Treatment. Retina, 32, S205-S210. https://doi.org/10.1097/IAE.0b013e31825bc0de</mixed-citation></ref><ref id="scirp.123211-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Grossniklaus, H.E. and Green, W.R. (2004) Choroidal Neovascularization. American Journal of Ophthalmology, 137, 496-503. https://doi.org/10.1016/j.ajo.2003.09.042</mixed-citation></ref><ref id="scirp.123211-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Wu, J., Xu, Q. and Luan, J. (2021) Vitrectomy with Fovea-Sparing ILM Peeling versus Total ILM Peeling for Myopic Traction Maculopathy: A Meta-Analysis. European Journal of Ophthalmology, 31, 2596-2605. https://doi.org/10.1177/1120672120970111</mixed-citation></ref><ref id="scirp.123211-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Ouyang, P.B., Duan, X.C. and Zhu, X.H. (2012) Diagnosis and Treatment of Myopic Traction Maculopathy. International Journal of Ophthalmology, 5, 754-758.</mixed-citation></ref><ref id="scirp.123211-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Cheong, K.X., Xu, L., Matsui, K.O., Sabanayagam, C., Saw, S.M. and Hoang, Q.V. (2022) An Evidence-Based Review of the Epidemiology of Myopic Traction Maculopathy. Survey of Ophthalmology, 67, 1603-1630. https://doi.org/10.1016/j.survophthal.2022.03.007</mixed-citation></ref></ref-list></back></article>